• 1
    Duesberg CA, Feldman EC, Nelson RW, et al. Magnetic resonance imaging for diagnosis of pituitary macrotumors in dogs. J Am Vet Med Assoc 1995;206:657662.
  • 2
    Mauldin GN, Burk RL. The use of diagnostic computerized tomography and radiation therapy in canine and feline hyperadrenocorticism. Probl Vet Med 1990;2:557564.
  • 3
    Thuomas KA. Pituitary microadenoma. MR appearance and correlation with CT. Acta Radiol 1999;40:663.
  • 4
    Feldman EC, Nelson RW. Canine and Feline Endocrinology and Reproduction, 3rd ed. Philadelphia, PA: WB Saunders Co; 2003.
  • 5
    Nelson RW, Ihle SL, Feldman EC. Pituitary macroadenomas and macroadenocarcinomas in dogs treated with Lysodren for pituitary-dependent hyperadrenocorticism: 13 cases (1981–1986). J Am Vet Med Assoc 1989;194:16121617.
  • 6
    Burger PC, Scheithauer BW, Vogel FS. Region of the Sella Turcica. Surgical Pathology of the Nervous System and its Coverings, 4th ed. Philadelphia, PA: Elsevier Science; 2002.
  • 7
    Kontogeorgos G. Classification and pathology of pituitary tumors. Endocrine 2005;28:2735.
  • 8
    Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary carcinoma: A clinicopathologic study of 15 cases. Cancer 1997;79:804812.
  • 9
    Kiupel M, Capen CC, Miller M, et al. Histological Classification of Tumors of the Endocrine System of Domestic Animals, 2nd Series. Washington, DC: Armed Forces Institute of Pathology; 2008.
  • 10
    Greco DS, Behrend EN, Brown SA, et al. Pharmacokinetics of exogenous corticotropin in normal dogs, hospitalized dogs with non adrenal illness and adrenopathic dogs. J Vet Pharmacol Ther 1998;21:369374.
  • 11
    Kooistra HS, Voorhout G, Mol JA, et al. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol 1997;152:387394.
  • 12
    Li-Ng M, Sharma M. Invasive pituitary adenoma. J Clin Endocrinol Metab 2008;93:32843285.
  • 13
    Lopes MB, Scheithauer BW, Schiff D. Pituitary carcinoma: Diagnosis and treatment. Endocrine 2005;28:115121.
  • 14
    Meij BP, Lopes MB, Ellegala DB, et al. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 2002;96:195208.
  • 15
    Thapar K, Kovacs K, Scheithauer BW, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody. Neurosurgery 1996;38:99106.
  • 16
    Wood FD, Pollard RE, Uerling MR, et al. Diagnostic imaging findings and endocrine test results in dogs with pituitary-dependent hyperadrenocorticism that did or did not have neurologic abnormalities: 157 cases (1989–2005). J Am Vet Med Assoc 2007;231:10811085.
  • 17
    Hanson JM, Van't HM, Voorhout G, et al. Efficacy of transsphenoidal hypophysectomy in treatment of dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 2005;19:687694.
  • 18
    Hanson JM, Teske E, Voorhout G, et al. Prognostic factors for outcome after transsphenoidal hypophysectomy in dogs with pituitary-dependent hyperadrenocorticism. J Neurosurg 2007;107:830840.
  • 19
    Theon AP, Feldman EC. Megavoltage irradiation of pituitary macrotumors in dogs with neurologic signs. J Am Vet Med Assoc 1998;213:225231.
  • 20
    Kent MS, Bommarito D, Feldman E, et al. Survival, neurologic response, and prognostic factors in dogs with pituitary masses treated with radiation therapy and untreated dogs. J Vet Intern Med 2007;21:10271033.